Innodem Neurosciences Revenue and Competitors
Estimated Revenue & Valuation
- Innodem Neurosciences's estimated annual revenue is currently $4.5M per year.
- Innodem Neurosciences's estimated revenue per employee is $251,000
Employee Data
- Innodem Neurosciences has 18 Employees.
- Innodem Neurosciences grew their employee count by -25% last year.
Innodem Neurosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CTO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | VP Neurosciences Research | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | Director, Project Management Office (PMO) | Reveal Email/Phone |
6 | Founder, CEO & Chief Scientific Officer | Reveal Email/Phone |
7 | Co-Founder & Chief Business Officer | Reveal Email/Phone |
8 | Clinical Research Manager | Reveal Email/Phone |
9 | Vice-President Research and Development in Artificial Intelligence | Reveal Email/Phone |
Innodem Neurosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.6M | 21 | -32% | $26.7M | N/A |
#2 | $45.4M | 181 | 12% | N/A | N/A |
#3 | $0.5M | 4 | -80% | $4M | N/A |
#4 | $90.9M | 362 | 9% | N/A | N/A |
#5 | $11.3M | 45 | 45% | N/A | N/A |
#6 | $12.6M | 50 | 4% | N/A | N/A |
#7 | $46.9M | 187 | -18% | N/A | N/A |
#8 | $6.5M | 26 | 8% | N/A | N/A |
#9 | $66.5M | 212 | 0% | $64.7M | N/A |
#10 | $33.1M | 132 | 8% | N/A | N/A |
What Is Innodem Neurosciences?
Innodem Neurosciences is committed to improving the effectiveness and quality of life and care of patients with neurological problems. Innodem works with the pharmaceutical industry, leading medical professionals, and artificial intelligence experts to develop and promote Eye Movement Biomarkers (EMBs) & Gaze Mapping Biomarkers (GMBs) as important clinical assessment tools in the field of neurology. It is building a series of disease-specific tests embodied in an intuitive App that captures EMB & GMB data. The vision is that over time, while leveraging the latest advances in machine and deep learning, this EMB/GMB platform will assist users to accurately diagnose and monitor neurological disorders affecting eye-movements or cognition such as multiple sclerosis, Alzheirmer's, Parkinson's or related disorders, Frontotemporal dementia, Cancer-related cognitive impairment (Chemo Brain) and many others.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$4.5M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Montreal
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 18 | -10% | N/A |
#2 | $0.9M | 18 | -5% | $8M |
#3 | $1.9M | 18 | -5% | N/A |
#4 | $0.7M | 18 | 38% | N/A |
#5 | $2.2M | 18 | 64% | N/A |